Home/Filings/5/0001031927-10-000002
5//SEC Filing

Mitchell Harry 5

Accession 0001031927-10-000002

CIK 0001031927other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 3:40 PM ET

Size

14.0 KB

Accession

0001031927-10-000002

Insider Transaction Report

Form 5
Period: 2009-12-31
Mitchell Harry
CFO and COO
Transactions
  • Award

    Common Stock

    2008-05-30+11,187892,687 total
  • Award

    Common stock

    2009-02-20+175,000892,687 total
  • Award

    Common stock

    2009-06-15+175,000892,687 total
  • Disposition to Issuer

    Non-qualified stock option

    2009-02-20$2.39/sh250,000$597,500892,687 total
    Exercise: $2.39Exp: 2017-09-14Common stock (250,000 underlying)
  • Exercise of In-Money

    Non-qualified stock options

    2008-05-30$0.21/sh+12,500$2,625892,687 total
    Exercise: $0.21From: 2007-01-30Exp: 2017-01-30Common stock (12,500 underlying)
Footnotes (4)
  • [F1]The recipient transacted a Cashless Exercise of 12,500 NQSOs on May 30, 2008.
  • [F2]Includes 475,000 shares that may be acquired by Mr. Mitchell within 60 days upon the exercise of stock options and 1,500 shares of common stock which Mr. Mitchell may acquire within 60 days upon exercise of warrants.
  • [F3]One third of the options vested on September 14, 2007, options to purchase 83,333 shares vested on September 14, 2008, and the final one third (83,333) would have vested on September 14, 2009.
  • [F4]The restricted shares shall vest upon the first to occur of (i) FDA approval of the Companys Symphony tCGM System; or (ii) the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for liquid proceeds, which was defined as (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities.

Issuer

Echo Therapeutics, Inc.

CIK 0001031927

Entity typeother

Related Parties

1
  • filerCIK 0001367655

Filing Metadata

Form type
5
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 3:40 PM ET
Size
14.0 KB